About this event
The webinar is free for doctors and nurses working within the relevant field.
Representatives from the pharmaceutical industry are kindly asked to contact Charlotte Knudtzen at ckn@bpno.dk or Ina Bøgkjær at ibo@bpno.dk for further information regarding participation.
Please note that the Registration deadline: October 12, 2025
Make sure to sign up before this date to secure your spot.
PROGRAM
Chair: Paulus Rommer, Medical University of Vienna, Austria
Intro 16:00-16:05
Paulus Rommer, Medical University of Vienna, Austria
The immunopathological hallmarks of neuromyelitis optica spectrum disorder (NMOSD) 16:05-16:20
Nikolaos Grigoriadis, Aristotle University of Thessaloniki, Greece
The future of immunotherapies in NMOSD, MOGAD, and autoimmune encephalitis 16:20-16:35
Paul Friedemann, Charité-Universitätsmedizin Berlin, Germany
Immunotherapies in NMOSD, and MOGAD 16:35-16:50
Paulus Rommer, Medical University of Vienna, Austria
Socioeconomic consequences of AQP4+-NMOSD 16:50-17:05
Viktoria Papp, Odense University Hospital, Denmark
Q&A 17:05-17:30
The program is subject to change.
Sponsors
Hosted by
-
Team member
BestPractice NordicBN T
-
Guest speaker
Zsolt Laszlo IllésZL G
-
Guest speaker
Paulus RommerPR G
-
Guest speaker
Nikolaos Grigoriadis MD, PhD Professor of Neurology @ Aristotle University of ThessalonikiNG G
-
Guest speaker
Viktoria PappVP G
-
Guest speaker
Paul FriedemannPF G
-
Guest speaker
Jan Andreasen :-)JA G
BestPractice Nordic
BestPractice Nordic improves public health and patient care through specialized content for healthcare professionals in Nordic countries.
